SEC Filing Document

Company: Jones Ventures INTL Acquisition1 Corp
Ticker: 
CIK: 2129056
Filing Type: DRS
Document Type: DRS
Date Filed: 2026-04-13
Accession Number: 0001213900-26-042636
Exchange: 
SIC Code: 6770
SIC Description: Blank Checks
URL: https://www.sec.gov/Archives/edgar/data/2129056/000121390026042636/filename1.htm

Chunk 59 of 140
Word Count: 1497
Character Count: 9405

Document Content:

24 months from the closing of this offering or until such earlier liquidation date as our board of directors may approve, to consummate our initial business combination. If we anticipate that we may be unable to consummate our initial business combination within such 24-month period, we may seek shareholder approval to amend our amended and restated memorandum and articles of association to extend the date by which we must consummate our initial business combination. If we seek shareholder approval for an extension, holders of public shares will be offered an opportunity to vote on the extension and to redeem their shares at a per share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned thereon (less taxes paid and payable), divided by the number of then issued and outstanding public shares, subject to applicable law. Table of Contents DIVIDEND POLICY

We have not paid any cash dividends on our ordinary shares to date and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of our initial business combination. Further, if we incur any indebtedness in connection with our initial business combination, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith. If we increase or decrease the size of the offering, we will effect a share dividend or a share contribution back to capital or other appropriate mechanism, as applicable, with respect to our Class B ordinary shares immediately prior to the consummation of the offering in such amount so that the founder shares will continue to represent 25% of our issued and outstanding ordinary shares upon the consummation of this offering (not including the private placement units), which could cause dilution to our other shareholders. Such dilution could materially increase to the extent that the anti-dilution provision of the founder shares results in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the founder shares at the time of our initial business combination to maintain the number of founder shares at 25%.

Table of Contents

Dilution

The difference between the public offering price per Class A ordinary share and the net tangible book value (“NTBV”) per Class A ordinary share after this offering constitutes the dilution to investors in this offering. NTBV per share is determined by dividing our NTBV, which is our total tangible assets less total liabilities (including the value of Class A ordinary shares that may be redeemed for cash), by the number of outstanding Class A ordinary shares.

The below calculations (a) assume that (i) no ordinary shares are issued to shareholders of a potential business combination target as consideration or issuable by a post-business combination company, for instance under an equity or employee share purchase plan, (ii) no ordinary shares and convertible equity or debt securities are issued in connection with additional financing that we may seek in connection with our initial business combination (however, we may need to issue ordinary shares or convertible equity or debt securities in the circumstances described above, as we intend to target an initial business combination with a target company whose enterprise value is greater than the net proceeds of this offering and the sale of private placement units), and (iii) no working capital loans are converted into Class A ordinary shares, as further described in this prospectus, and (b) assume the issuance of 20,645,000 Units (or 23,645,000 Units if the underwriters’ over-allotment option is exercised in full) and that there are 7,666,667 Class B ordinary shares issued and outstanding (up to 1,000,000 of which are assumed to be forfeited in the scenario in which the over-allotment option is not exercised in full) and 2,000,000 Class A ordinary shares (up to 2,300,000 if the over-allotment option is exercised) upon the conversion of the Share Rights and 64,500 Class A ordinary shares upon the conversion of the private placement units Share Rights. Further, the issuance of additional ordinary or preference shares may significantly dilute the equity interest of our public shareholders, which dilution would increase further to the extent that the anti-dilution provisions of the Class B ordinary shares result in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares at the time of our business combination.

Because our Sponsor acquired the founder shares at a nominal price, our public shareholders will incur immediate and material dilution upon the closing of this offering, assuming no value is ascribed to the rights included in the units. Further, the Class A ordinary shares issuable in connection with the conversion of the founder shares will result in material dilution to our public shareholders due to the anti-dilution rights of our founder shares that may result in an issuance of Class A ordinary shares on a greater than one-for-one basis upon conversion. Further, our public shareholders may experience material dilution if the $1,500,000 in working capital loans is fully advanced by the Sponsor and the Sponsor elects to convert the working capital loans into private placement units at $10.00 per unit, resulting in the Sponsor receiving an additional 150,000 private units. Additionally, upon exercise of the private placement rights, we will issue an aggregate of 64,500 Class A ordinary shares (including if the overallotment option is exercised in full) to be purchased by our Sponsor and Jones simultaneously with the closing of this offering. The exercise of such private placement rights would cause the actual dilution to the public shareholders to be higher, particularly in certain circumstances specified in the right agreement where a cashless exercise of the private placement rights is utilized along with a cashless exercise of the public rights.

Table of Contents

The following table illustrates the difference between the public offering price per Class A ordinary shares and our NTBV per share, as adjusted to give effect to this offering and assuming redemption of our public shares at varying levels and the full exercise and no exercise of the over-allotment option:

As of December 31, 2025

Offering Price of $10.00 p er Un it 25% of Maximum Redemptions 50% of Maximum Redemptions 75% of Maximum Redemptions Maximum Redemptions

NTBV NTBV Difference between NTBV and Offering Price NTBV Difference between NTBV and Offering Price NTBV Difference between NTBV and Offering Price NTBV Difference between NTBV and Offering Price

Assuming Full Exercise of Over-Allotment Option

Assuming No Exercise of Over-Allotment Option

As of December 31, 2025

No Redemptions 25% of Maximum Redemptions 50% of Maximum Redemptions 75% of Maximum Redemptions Maximum Redemptions

Without Over- Allotment With Over- Allotment Without Over- Allotment With Over- Allotment Without Over- Allotment With Over- Allotment Without Over- Allotment With Over- Allotment Without Over- Allotment With Over- Allotment

Public offering price $	10.00 $	10.00 $	10.00 $	10.00 $	10.00 $	10.00 $	10.00 $	10.00 $	10.00 $	10.00

Net tangible book deficit per share before this offering (0.02	) (0.02	) (0.02	) (0.02	) (0.02	) (0.02	) (0.02	) (0.02	) (0.02	) (0.02	)

Increase per share attributable to public shareholders 7.39 7.41 6.80 6.82 5.87 5.89 4.18 4.21 0.18 0.19

Pro forma net tangible book value per share after this offering and the sale of the private placement units 7.37 7.39 6.78 6.80 5.85 5.87 4.16 4.19 0.16 0.17

Dilution per share to public shareholders $	2.63 2.61 3.22 3.20 4.15 4.13 5.84 5.81 9.84 9.83

Percentage of dilution to public shareholders 26.30	% 26.10	% 32.20	% 32.00	% 41.50	% 41.30	% 58.40	% 58.10	% 98.40	% 98.30	%

Table of Contents

For each of the redemption scenarios above, the NTBV was calculated as follows:

As of December 31, 2025

No Redemptions 25% of Maximum Redemptions 50% of Maximum Redemptions 75% of Maximum Redemptions Maximum Redemptions

Without Over- Allotment With Over- Allotment Without Over- Allotment With Over- Allotment Without Over- Allotment With Over- Allotment Without Over- Allotment With Over- Allotment Without Over- Allotment With Over- Allotment

Numerator:

Net tangible book deficit before this offering $	(142,398	) $	(142,398	) $	(142,398	) $	(142,398	) $	(142,398	) $	(142,398	) $	(142,398	) $	(142,398	) $	(142,398	) $	(142,398	)

Net proceeds from this offering and the sale of private placement units (1) 201,400,000 231,400,000 201,400,000 231,400,000 201,400,000 231,400,000 201,400,000 231,400,000 201,400,000 231,400,000

Plus: Offering costs accrued for or paid in advance, excluded from tangible book value 122,601 122,601 122,601 122,601 122,601 122,601 122,601 122,601 122,601 122,601

Less: Over-allotment liability (187,800	) — (187,800	) — (187,800	) — (187,800	) — (187,800	) —

Less: Amounts paid for redemptions (2) — — (50,000,000	) (57,500,000	) (100,000,000	) (115,000,000	) (150,000,000	) (172,500,000	) (200,000,000	) (230,000,000	)